PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for JNJ (Johnson & Johnson) from 1990 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Johnson & Johnson stock (JNJ) PE ratio as of Jan 20 2021 is 25.53. More Details

Johnson & Johnson PE Ratio (TTM) Chart

EMBED

Johnson & Johnson PE Ratio (TTM) Historical Data

Total 1256
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Johnson & Johnson PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-01-2125.5 2020-11-1923.1
2021-01-2025.5 2020-11-1823.2
2021-01-1925.6 2020-11-1723.5
2021-01-1825.2 2020-11-1623.7
2021-01-1525.2 2020-11-1323.6
2021-01-1425.3 2020-11-1223.3
2021-01-1324.8 2020-11-1123.2
2021-01-1224.9 2020-11-1023.3
2021-01-1125.1 2020-11-0923.0
2021-01-0825.2 2020-11-0622.4
2021-01-0725.2 2020-11-0522.0
2021-01-0625.1 2020-11-0421.9
2021-01-0524.9 2020-11-0321.8
2021-01-0424.6 2020-11-0221.8
2021-01-0124.8 2020-10-3021.6
2020-12-3124.8 2020-10-2921.6
2020-12-3024.5 2020-10-2821.8
2020-12-2924.2 2020-10-2722.5
2020-12-2824.1 2020-10-2622.6
2020-12-2524.0 2020-10-2322.8
2020-12-2424.0 2020-10-2222.8
2020-12-2323.9 2020-10-2122.6
2020-12-2224.0 2020-10-2022.7
2020-12-2124.1 2020-10-1922.7
2020-12-1824.3 2020-10-1623.3
2020-12-1724.2 2020-10-1523.1
2020-12-1623.5 2020-10-1423.3
2020-12-1523.7 2020-10-1323.3
2020-12-1423.4 2020-10-1223.9
2020-12-1124.1 2020-10-0923.7
2020-12-1023.9 2020-10-0823.4
2020-12-0924.1 2020-10-0723.3
2020-12-0823.8 2020-10-0623.0
2020-12-0723.4 2020-10-0523.3
2020-12-0423.6 2020-10-0223.0
2020-12-0323.4 2020-10-0123.2
2020-12-0223.3 2020-09-3023.4
2020-12-0123.2 2020-09-2923.1
2020-11-3022.8 2020-09-2823.1
2020-11-2722.6 2020-09-2525.6
2020-11-2622.6 2020-09-2425.4
2020-11-2522.6 2020-09-2325.4
2020-11-2422.6 2020-09-2225.3
2020-11-2322.6 2020-09-2125.5
2020-11-2023.0 2020-09-1826.2

Johnson & Johnson PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Drug Manufacturers » NAICS : 325412 NAICS : 2834
Address One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.